Barclays analyst John Babcock raised the firm’s price target on Copart (CPRT) to $33 from $32 and keeps an Underweight rating on the shares following the fiscal Q1 report. The company’s insurance volumes are showing the impact of elevated uninsured rates and “market share evolution,” the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPRT:
